Respiratory Tract Infec1ons Long Term Care. Dr Karsten Hammond Infec1ous Diseases 28 March 2015

Similar documents
PNEUMONIA. I. Background 6 th most common cause of death in U.S. Most common cause of infection related mortality

The McMaster at night Pediatric Curriculum

Upper...and Lower Respiratory Tract Infections

POLICY FOR TREATMENT OF LOWER RESPIRATORY TRACT INFECTIONS

WHO posi)on paper on pneumococcal vaccines. Geneva, Switzerland Published in the Weekly Epidemiological Record on 6 Apr 2012

Community Acquired Pneumonia. Abdullah Alharbi, MD, FCCP

Brice Taylor Assistant Professor Division of Pulmonary and Critical Care Medicine

Respiratory tract infections. Krzysztof Buczkowski

Community Acquired Pneumonia

PULMONARY EMERGENCIES

Critical Care Nursing Theory. Pneumonia. - Pneumonia is an acute infection of the pulmonary parenchyma

Nosocomial Pneumonia. <5 Days: Non-Multidrug-Resistant Bacteria

Charles Krasner, M.D. University of NV, Reno School of Medicine Sierra NV Veterans Affairs Medical Center

Pneumonia in Older Adults: An Update

CAP, HCAP, HAP, VAP. 1. In 1898, William Osler described community-acquired pneumonia as:

URIs and Pneumonia. Elena Bissell, MD 10/16/2013

CLAIRE NOWLAN & SAM SEARLE. Pneumonia in the nursing home

Antimicrobial Stewardship in Community Acquired Pneumonia

Guidelines/Guidance/CAP/ Hospitalized Child. PHM Boot Camp 2014 Jay Tureen, MD June 19, 2014

Bronchitis/Pneumonia Core Content Keith Conover, M.D., FACEP /15/02 Clinical Spectrum Chest pain, shoulder pain, neck pain, abdominal pain,

Respiratory Infections

Clostridium difficile coli%s. John K. Midturi January 2013

Pneumonia Community-Acquired Healthcare-Associated

Choosing an appropriate antimicrobial agent. 3) the spectrum of potential pathogens

Antibiotic Use in the Outpatient Setting. Ryan Bariola, MD FIDSA Visi4ng Clinical Associate Professor of Medicine

Preventing & Controlling the Spread of Infection

MICROBIOLOGICAL TESTING IN PICU

Catherine Casey S. Jones,

Treatment of febrile neutropenia in patients with neoplasia

Fraser Health pandemic preparedness

Management of URTI s in Children

PNEUMONIA IN CHILDREN. IAP UG Teaching slides

Turkish Thoracic Society

Pneumonia. Dr. Rami M Adil Al-Hayali Assistant professor in medicine

Community Acquired & Nosocomial Pneumonias

Pneumococcal Disease and Pneumococcal Vaccines

PNEUMONIA. Patient Case: Chief Complaint: I have been short of breath and have been coughing up rust-colored phlegm for the past 3 days.

Aspiration pneumonia in older people

Streptococci facultative anaerobe

RESPIRATORY TRACT INFECTIONS. CLS 212: Medical Microbiology

INFECTIOUS DISEASES IN THE LONG TERM CARE FACILITY

Eun-Young Kang, M.D., Jae Wook Lee, M.D., Ji Yung Choo, M.D., Hwan Seok Yong, M.D., Ki Yeol Lee, M.D., Yu-Whan Oh, M.D.

Community Acquired Pneumonia Pediatric Ages 3 month to 18 years Clinical Practice Guideline MedStar Health Antibiotic Stewardship

WHO posi)on paper on influenza vaccines*

KAISER PERMANENTE OHIO COMMUNITY ACQUIRED PNEUMONIA

How do we define pneumonia?

Clinical Practice Guidelines for Nursing- and Healthcareassociated Pneumonia (NHCAP) [Complete translation] $

Objectives. Pneumonia. Pneumonia. Epidemiology. Prevalence 1/7/2012. Community-Acquired Pneumonia in infants and children

Upper Respiratory tract Infec1on. Gassem Gohal FAAP FRCPC

DELL CHILDREN S MEDICAL CENTER EVIDENCE-BASED OUTCOMES CENTER. Community Acquired Pneumonia

Hospital-acquired Pneumonia

Pneumonia 2017 OMAR PIRZADA

I have no disclosures

Lecture Notes. Chapter 16: Bacterial Pneumonia

Pneumonia. Definition of pneumonia Infection of the lung parenchyma Usually bacterial

Creating a User Defined Pneumonia-Specific Syndrome in ESSENCE. Preventive Medicine Directorate September 2016

Chapter 22. Pulmonary Infections

RESPIRATORY TRACT INFECTIONS. CLS 212: Medical Microbiology Zeina Alkudmani

Severe β-lactam allergy. Alternative (use for mild-moderate β-lactam allergy) therapy

Antibiotics, Expectorants, and Cough Suppressants. Center For Cardiac Fitness Pulmonary Rehab The Miriam Hospital

Pediatric Respiratory Infections

Community-Acquired Pneumonia. Lisa G. Winston, MD University of California, San Francisco San Francisco General Hospital. Nothing to disclose.

27/11/2012. Parainfuenza 1, 2 3 Rhinovirus Coronavirus Adenovirus Respiratory syncytial virus (RSV) Chlamydophila pneumoniae Mycoplasma pneumonite

Diffusion: Oxygen in the alveoli move into capillaries to go to the body, and carbon

Haemophilus influenzae

Community Acquired Pneumonia - Pediatric Clinical Practice Guideline MedStar Health Antibiotic Stewardship

INFLUENZA AND OTHER RESPIRATORY VIRUSES

Bacterial Pneumonia Acquired in Nursing Homes

For more information about how to cite these materials visit

Pediatric Asthma. Fernando D. Mar,nez, M.D. Asthma and Airways Disease Research Center The University of Arizona

Bradley A. Sharpe, M.D. Associate Professor Medicine Department of Medicine UCSF -- William Osler, M.D.

Isolation Precautions in Clinics

Beta-lactamase production should have no effect on Azithromycin activity.

Update on Rhinosinusitis 2013 AAP Guidelines Review

COPD exacerbation. Dr. med. Frank Rassouli

Introduction to Microbes and Infectious Disease

pneumonia 2015;6:48 56

Infections of the head, neck, and lower respiratory tract

PNEUMONIA. Pneumonia is an inflammation of the lungs caused by bacteria, viruses, fungi, rickettsiae and other microorganisms.

Pneumonia: The Forgotten Killer

Upper Respiratory Tract Infections

Unit II Problem 2 Microbiology Lab: Pneumonia

AXITAB-CV TAB. COMPOSITION :

Pneumonia Aetiology Why is it so difficult to distinguish pathogens from innocent bystanders?

Antibiotic Stewardship for Skin and Soft Tissue Infection and Respiratory Tract Infections

Frailty in Geriatric Trauma Pa1ents

Pathogens of the Respiratory System

Infective Endocarditis Empirical therapy Antibiotic Guidelines. Contents

Chapter 10 Respiratory System J00-J99. Presented by: Jesicca Andrews

MCH-Immunization Conference. September 2012

Beta-lactamase production should have no effect on Azithromycin activity.

2013 WEBINAR SERIES STATE OF THE SCIENCE: DEMENTIA EVALUATION AND MANAGEMENT FAMILIES AMONG DIVERSE OLDER ADULTS AND THEIR

Clinical Pearls Infectious Diseases. Pritish K. Tosh, MD MN ACP Nov 7, [Answers and discussion slides will be posted after the meeting]

Prefe f rred d t e t rm: : rhi h no n s o inu n s u iti t s

Patient information: Pneumonia in adults (Beyond the Basics)

Upper Respiratory Tract Infections / 42

Respiratory Infec0on. 2 nd Year Revision Phil Short Clinical Research Fellow

declara&ons Clostridium difficile infec&on. Time to wake up and smell the..., um, nevermind. OK, next slide please. Bruce Dalton, BScPhm. PharmD.

Transcription:

Respiratory Tract Infec1ons Long Term Care Dr Karsten Hammond Infec1ous Diseases 28 March 2015

Disclosures I have no financial rela1onships to disclose

82 yo Female In LTC for two years, total care from Moderate demen1a Immobility and dysphagia following CVAs Thickened fluids, not tube fed Over several days noted to be more confused, respiratory rate elevated (25) Area of crepita1ons on exam No produc1ve cough O2 sats 96

Send to hospital? Send for x- ray? Most likely pathogen? Start an1bio1cs? Azithromycin? Amoxicillin- clavulanate? Moxifloxacin? Amoxicillin? Dura1on??

Objec1ves For pneumonia in long- term care, review the: Epidemiology and microbiology Presenta1on and diagnosis Treatment and preven1on

Epidemiology of Pneumonia in LTC 2004 US survey of LTC facili1es 2.2% of pa1ents had diagnosis of pneumonia Second only to UTI at 5.2% 8-21% of pa1ents in LTC per year diagnosed with pneumonia In a Veterans Affairs study mortality high 23% at 14 days 75% at one year (vs 40% in controls)

All Pneumonia is From Aspira1on Viruses and some atypical pathogens are inhaled Bacterial pneumonia pathogens ini1ally colonize oropharynx Microaspira1on delivers these organisms into the lung

Risk Factors for Pneumonia in LTC Debilita1on Swallowing difficul1es NG feeds Confusion and seda1on Chronic lung disease

What Causes Pneumonia in LTC?

Viruses Influenza common, severe Other respiratory viruses also common 382 pa1ents had serum drawn twice a year apart For a vitamin E study Serologic response to respiratory viruses 41% had at least one viral infec1on Most common was metapneumovirus Viruses other than influenza also cause outbreaks (RSV, metapneumovirus)

Clues to a Diagnosis of a Viral Infec1on Rhini1s/rhinorrhea Conjunc1vi1s Wheeze Lack of sputum produc1on Although ohen absent in bacterial pneumonia Note that with some viruses (influenza, parainfluenza) significant consolida1on can occur

Atypicals Chlamydophila pneumoniae Can occur, severity is low Legionella pneumophila Outbreaks can occur in LTC Spread by HVAC systems Illness typically very severe Very liile legionella in BC Mycoplasma pneumoniae Not a significant concern in LTC sejngs

TB in LTC Many pa1ents in LTC at higher risk for TB Reac1va1on increased due to age, coomorbidi1es More likely to have latent TB as many grew up in pre- treatment era LTC pa1ents should be screened before entering LTC Not sure what BC guidelines are Screening can s1ll miss cases

Bacteria Elderly pa1ents in the community S. pneumoniae the significant pathogen In LTC, poorly studied Hard to get sputum cultures from weak pa1ents Diagnos1cs not as available as in acute care Liile focus on this popula1on

Spanish Series on Pneumonia in LTC Looked at 150 consecu1ve pa1ents admiied from LTC to hospital for pneumonia Only iden1fied a cause in 57 cases (38%) S. pneumoniae most common 22% of all cases, 57% of cases with micro diagnosis Gram nega1ves and Staphylococcus aureus 7% of all cases, 18% of cases with micro diagnosis

Aspira1on Pathogens Aspira1on pneumonia aher macro- aspira1on Normal oral flora (majority) Streptococcus virdans group Anaerobes Coliforms (possible) Major pathogen if gastric contents aspirated Colonize the oropharynx of unwell pa1ents Same process as in hospital acquired pneumonia

Causes of Pneumonia in LTC: Summary Viral pneumonia is common Bacterial causes unclear but S. pneumoniae most common Gram nega1ves and S. aureus more common than in community but s1ll uncommon Atypicals not a significant problem (in BC) Aspira1on pneumonia involves oral streptococci, anaerobes and possibly coliforms

Aspira1on Pneumonia

Aspira1on 3 Clinical Condi1ons Aspira1on pneumoni1s Chemical pneumoni1s secondary to gastric acid Rapid onset (hours), does not need an1bio1cs Aspira1on with obstruc1on Secondary to mechanical obstruc1on with food Aspira1on pneumonia Oropharyngeal flora or gastrointes1nal flora

Aspira1on Pneumonia Presenta1on Ohen indolent Foul smelling sputum Usually no significant aspira1on event Microaspira1on Forms lung abscesses if not caught early

Presenta1on of Pneumonia in LTC Compared to non- LTC pa1ents, less likely to: Have fever Have produc1ve cough Have pleuri1c pain More likely to: Have confusion Have dehydra1on Have a decrease in func1on

Diagnosis Difficult given resources in LTC Clinical signs Tachypnea Fever, low O2 sats, dehydra1on and confusion Exam Area of consolida1on Inves1ga1ons Leukocytosis and abnormal CXR Sputum culture if possible Blood culture not helpful

Treatment When to Transfer Subjec1ve If care direc1ve allows transfer: O2 sats <90 Unable to take po medica1ons RR elevated and fa1guing Severe dehydra1on

Treatment Won t cover IV treatments Choosing oral an1bio1cs depends on Likely pathogens Co- morbidi1es and other medica1ons Allergies Treatment guidelines are not evidence based for pneumonia in LTC

IDSA HAP/HCAP/VAP Guidelines HAP - hospital acquired pneumonia VAP - ven1lator acquired pneumonia HCAP Health- Care Associated Pneumonia In hospital in prior 90 days In nursing home On dialysis Recent IV an1bio1cs or chemotherapy

IDSA Guidelines Guidelines lump HAP, VAP and HCAP together Suggest broad spectrum IV an1bio1cs No specific sugges1ons for LTC No sugges1ons for ini1al oral therapy

VIHA Guidelines VIHA has guidelines for community acquired pneumonia Includes specific sugges1ons for LTC First line in community amoxicillin alone First line in LTC Amoxicillin- clavulanate 500 1d or 875 bid If there is a penicillin allergy Cefuroxime 500 bid or moxifloxacin 400 daily

Principles Atypical therapy (usually) not needed Adding second drug may help in S. pneumo Not clear, so not suggested at this 1me Use amoxicillin- clavulanate for increased gram nega1ve and MSSA coverage Also excellent anaerobic coverage for aspira1on

Allergies to Penicillin If mild reac1on ie, not anaphylaxis, angioedema (maybe hives) Cefuroxime 500 bid Poor anaerobic coverage, add metronidazole if needed If severe reac1on Moxifloxacin 400 daily Good anaerobic coverage

Adverse Effects Amoxicillin- clavulanate Nausea, diarrhea quite common Moxifloxacin Diarrhea common, can induce C. difficile coli1s QT prolonga1on, watch with other drugs Cefuroxime Diarrhea (less common)

What About Macrolides? Resistance In VIHA, ~25% of S. pneumoniae Coverage Does not cover anaerobes in aspira1on Drug interac1ons Common and can be severe

An1bio1c Selec1on Summary - 1 First line for all pneumonia in LTC Amoxicillin- clavulanate If mild penicillin allergy Cefuroxime Add metronidazole for aspira1on If severe penicillin allergy Moxifloxacin

An1bio1c Selec1on Summary - 2 Don t need to cover atypicals Moxifloxacin is not first line Don t use macrolides

Dura1on Trend in treatment of S. pneumoniae CAP is towards shorter courses Maximum 7 days if uncomplicated Need to lengthen if complicated, S. aureus Not studied in LTC pa1ents, but a 7 day course is reasonable for most Aspira1on pneumonia ohen forms lung abscesses If present, need weeks of therapy

Preven1on of Pneumonia in LTC Conserva1ve measures to reduce aspira1on Because all pneumonia is from aspira1on Thickened fluids Ea1ng while upright Oral care Poor den11on risk for aspira1on, even if tube fed Wearing dentures overnight doubles risk In the community elderly

Preven1on Pneumococcal Vaccine Two vaccines 13 valent conjugate vaccine Conjugate makes it more immunogenic Reduces pharyngeal coloniza1on 23 valent polysaccharide vaccine Does not decrease coloniza1on US guidelines say to use conjugate then polysaccharide in >65 Canada does not suggest conjugate for elderly Give one dose to >65, repeat once at 5 years

Efficacy of Pneumococcal Vaccine Efficacy Reduc1on in incidence in a study popula1on Effec1veness Reduc1on in incidence on a popula1on level 2013 Cochrane review efficacy: Invasive pneumococcal disease 74% All cause pneumonia 28%

Efficacy in LTC 2010 Japanese RCT of 1000 LTC pa1ents Mean age 85 23 valent vaccine used Significant protec1on over two years 64% reduc1on in pneumococcal pneumonia 45% reduc1on in all cause pneumonia 35% reduc1on in death from pneumococcal pneumonia

Summary Pneumonia in LTC is common and has a high mortality Caused by both viruses and bacteria S. pneumoniae the most common Atypicals rare Consider TB Diagnosis in LTC mainly clinical Tachypnea key symptom

Summary First line an1bio1c is amoxicillin- clavulanate In mild penicillin allergy, use cefuroxime In severe allergy, use moxifloxacin 7 days long enough for most cases Much longer if abscesses present Pneumococcal vaccine effec1ve in LTC Conserva1ve measures reduce aspira1on